Which statement indicates a need for further teaching about medication safety in a client with Cushing's syndrome?

Which statement indicates a need for further teaching about medication safety in a client with Cushing's syndrome?

• A. I need to read the labels on any over-the-counter medications I purchase.
• B. Taking my medications exactly as prescribed is essential.
• C. My family needs to be familiar with the signs and symptoms of hypoadrenalism.
• D. I could experience the signs and symptoms of hyperadrenalism because of Cushing's.

Answer: (A)

In Cushing's syndrome, medication safety means more than just following prescriptions; it requires awareness of how any added medicines, including over-the-counter products, can interact with glucocorticoid therapy and worsen symptoms. Exogenous steroids can cause or worsen hyperglycemia, hypertension, edema, and GI issues, and stopping steroids abruptly can precipitate adrenal insufficiency. Therefore, patients should not assume all OTC meds are harmless and should discuss any non-prescription products with their clinician before taking them. They also need to know about potential interactions and specific risks such as GI bleeding with NSAIDs while on steroids, and the possibility that some OTC items may contain steroids. The statement about reading labels on OTC medications shows an intention to be safety-conscious, but it does not address these specific risks or the need to consult with a healthcare provider before adding any OTC product. That gap indicates a need for further teaching to ensure the patient can safely navigate medication use in the context of Cushing's. The other points reflect appropriate safety practices—adherence to prescribed regimens, family awareness of hypoadrenalism signs, and understanding that hyperadrenalism-related symptoms can occur—so they align with proper management.

In Cushing's syndrome, medication safety means more than just following prescriptions; it requires awareness of how any added medicines, including over-the-counter products, can interact with glucocorticoid therapy and worsen symptoms. Exogenous steroids can cause or worsen hyperglycemia, hypertension, edema, and GI issues, and stopping steroids abruptly can precipitate adrenal insufficiency. Therefore, patients should not assume all OTC meds are harmless and should discuss any non-prescription products with their clinician before taking them. They also need to know about potential interactions and specific risks such as GI bleeding with NSAIDs while on steroids, and the possibility that some OTC items may contain steroids.

The statement about reading labels on OTC medications shows an intention to be safety-conscious, but it does not address these specific risks or the need to consult with a healthcare provider before adding any OTC product. That gap indicates a need for further teaching to ensure the patient can safely navigate medication use in the context of Cushing's. The other points reflect appropriate safety practices—adherence to prescribed regimens, family awareness of hypoadrenalism signs, and understanding that hyperadrenalism-related symptoms can occur—so they align with proper management.